Hyperosmolar hyperglycemic state

Last reviewed: 26 Apr 2022
Last updated: 12 Apr 2022

Summary

Definition

History and exam

Key diagnostic factors

  • altered mental status
More key diagnostic factors

Other diagnostic factors

  • polyuria
  • polydipsia
  • weight loss
  • weakness
  • dry mucus membranes
  • poor skin turgor
  • tachycardia
  • hypotension
  • seizures
  • hypothermia
  • shock
  • abdominal pain
  • focal neurologic signs
Other diagnostic factors

Risk factors

  • infection
  • inadequate insulin or oral antidiabetic therapy
  • acute illness in a known patient with diabetes
  • nursing home residents
  • failure to detect hyperglycemia
  • postoperative state
  • precipitating medications
  • total parenteral nutrition (TPN)
  • Cushing syndrome
  • hyperthyroidism
  • acromegaly
More risk factors

Diagnostic investigations

1st investigations to order

  • plasma glucose level
  • serum or urinary ketone level
  • serum BUN level
  • serum creatinine level
  • serum sodium level
  • serum potassium level
  • serum chloride level
  • serum magnesium level
  • serum calcium level
  • serum phosphate level
  • serum osmolality
  • anion gap calculation
  • serum lactate level
  • blood gas
  • urinalysis
  • liver function tests
  • CBC
More 1st investigations to order

Investigations to consider

  • chest x-ray
  • ECG
  • cardiac biomarkers
  • blood, urine, or sputum cultures
More investigations to consider

Treatment algorithm

ACUTE

all patients

ONGOING

HHS resolved and patient able to tolerate oral intake

Contributors

Authors

Guillermo Umpierrez, MD

Professor of Medicine

Emory University School of Medicine

Atlanta

GA

Disclosures

GU is partly supported by research grants from the National Center for Advancing Translational Sciences of the National Institutes of Health, under Award Number UL1TR002378, from the Clinical and Translational Science Award program, and a National Institutes of Health (NIH) grant U30, P30DK11102. GU has also received research grant support to Emory University for investigator-initiated studies from Novo Nordisk, Astra Zeneca, and Dexcom. GU is an author of a number of references cited in this topic.

Peer reviewers

Daniel Morganstein, MBBS, MA (Cantab), MRCP, PhD

Consultant Diabetologist

Beta Cell Unit

Chelsea and Westminster NHS Trust

London

UK

Disclosures

DM declares that he has no competing interests.

M. Cecilia Lansang, MD

Department of Medicine

Division of Endocrinology and Metabolism

Gainesville

University of Florida

FL

Disclosures

MCL has received speaker fees from Sanofi-Aventis and Novo Nordisk, makers of insulin products.

  • Differentials

    • Diabetic ketoacidosis (DKA)
    • Lactic acidosis
    • Alcohol ketoacidosis
    More Differentials
  • Guidelines

    • Standards of medical care in diabetes - 2022
    • Diabetic ketoacidosis and hyperglycemic hyperosmolar state
    More Guidelines
  • Patient leaflets

    Diabetes: what is it?

    Diabetes type 2: should I take insulin?

    More Patient leaflets
  • Videos

    Tracheal intubation: animated demonstration

    Bag-valve-mask ventilation: animated demonstration

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer